What is Evernow?
Evernow operates at the intersection of telemedicine and specialized women's health, providing a digital-first approach to menopause management. Since its inception in 2019, the company has leveraged scientific advancements to offer accessible, custom treatment plans for women navigating the complexities of hormonal changes. By integrating clinical expertise with a user-centric digital interface, Evernow has established itself as a key player in the healthtech sector, effectively bridging the gap between traditional medical care and the demand for convenient, personalized health solutions.
How much funding has Evernow raised?
Evernow has raised a total of $28.5M across 1 funding round:
Series A
$28.5M
Series A (2022): $28.5M with participation from Cameron Diaz, Gwyneth Paltrow, Coelius Capital, 8VC, New Enterprise Associates, Othman Laraki, Carla Harris, Drew Barrymore, and Refactor Capital
Key Investors in Evernow
8VC
8VC is a leading technology investment firm that focuses on backing industry-transforming companies across sectors including healthcare and Bio-IT.
New Enterprise Associates
Established in 1977, NEA is a prominent venture capital firm dedicated to helping entrepreneurs build and scale transformative businesses.
Refactor Capital
Refactor Capital is an early-stage venture firm that invests in founders addressing fundamental human problems through hard tech and innovation.
What's next for Evernow?
With the backing of prominent venture capital firms and strategic partners, Evernow is well-positioned to accelerate its growth trajectory. The current lifecycle stage, characterized by major enterprise-level funding, suggests a focus on scaling operations and enhancing its proprietary care delivery model. Future strategic initiatives will likely involve expanding the clinical team, deepening the integration of data-driven health insights, and potentially diversifying its service offerings to address a broader spectrum of women's health needs. As the company matures, its ability to maintain high standards of clinical efficacy while scaling will be the primary metric for long-term success in the competitive digital health landscape.
See full Evernow company page
